Protective effects of Ficus racemosa stem bark against doxorubucin-induced renal and testicular toxicity

Pharmacognosy Magazine

Volumn 9, Issue 34, 2013, Pages 130-134

  Ahmed, Faiyaz ^a,b   Urooj, Asna ^a   Karim, Alias A ^b  

^a UNIVERSITY OF MYSORE   (India)

^b Universiti Sains Malaysia   (Malaysia)

Author keywords

Doxorubicin; glutathione; histopathology; oxidative stress; thiobarbituric acid reactive substances

Indexed keywords

ACETONE; CREATININE; DOXORUBICIN; FICUS RACEMOSA EXTRACT; GLUTATHIONE; PLANT EXTRACT; PROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARK; CONTROLLED STUDY; FICUS RACEMOSA; HISTOPATHOLOGY; MALE; NEPHROTOXICITY; NONHUMAN; RAT; SOLVENT EXTRACTION; TESTIS DISEASE; UREA BLOOD LEVEL;

EID: 84879103278     PISSN: 09731296     EISSN: 09764062     Source Type: Journal    
DOI: 10.4103/0973-1296.111265     Document Type: Article

References (31)

1. Priestman T. Cancer chemotherapy in clinical practice. London: Springer-Verlag; 2008.
2. Ng R, Better N, Green MD. Anticancer agents and cardiotoxicity. Semin Oncol 2006;33:2-14. (Pubitemid 43214484)
3. Lui RC, Laregina MC, Herbold DR, Johnson FE. Testicular cytotoxicity of intravenous doxorubicin in rats. J Urol 1986;136: 940-3. (Pubitemid 16026257)
4. Injac R, Strukelj B. Recent advances in protection against doxorubicin-induced toxicity. Technol Cancer Res Treat 2008;7: 497-516.
5. Ratain MJ, Ewesuedo RB. Cancer chemotherapy. Berlin: Springer-Verlag; 1999. p. 76-83.
6. Quiles JL, Huertas JR, Battiono M, Mataix J, Ramírez-Tortosa MC. Antioxidant nutrients and adriamycin toxicity. Toxicology 2002;180:79-95. (Pubitemid 35248094)
7. Ananymous. The Wealth of India. Vol. 4. New Delhi: Council of Scientific and Industrial Research; 1952. p. 35-6.
8. Ahmed F, Urooj A. Antioxidant activity of various extracts of Ficus racemosa stem bark. National Journal of Life Sciences 2009;6:69-74.
9. Ahmed F, Urooj A. Glucose lowering, hepatoprotective and hypolipidemic activity of stem bark of Ficus racemosa in streptozotocin-induced diabetic rats. J Young Pharm 2009;1: 160-4.
10. Ahmed F, Hudeda S, Urooj A. Antihyperglycemic activity of Ficusracemosa bark extract in type II diabetic individuals. J Diabetes 2010;3:1-2.
11. Ahmed F, Sharanappa P, Urooj A. Antibacterial activities of various sequential extracts of Ficusracemosa stem bark. Pharmacognosy Journal 2010;2:203-6.
12. Ahmed F, Chandra JN, Manjunath S. Acetylcholine and memory enhancing activity of Ficusracemosa bark. Pharmacognosy Res 2011;3:246-9.
13. Ahmed F, Siddesha JM, Urooj A, Vishwanath BS. Radical scavenging and angiotensin converting enzyme inhibitory activities of standardized extracts of Ficusracemosa stem bark. Phytother Res 2010;24:1839-43.
14. Ahmed F, Urooj A. Hepatoprotective effects of Ficusracemosa stem bark against carbon tetrachloride-induced hepatic damage in albino rats. Pharm Biol 2010;48:210-6.
15. Ahmed F, Urooj A. Cardioprotective activity of standardized extract of Ficusracemosa stem bark against doxorubicin-induced toxicity. Pharm Biol 2012;50:468-73.
16. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7.
17. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animals tissues by thiobarbituric reaction. Anal Biochem 1979;95:351-8. (Pubitemid 9194347)
18. Herman EH, Ferrans VJ. Animal models of anthracycline cardiotoxicity: Basic mechanisms and cardioprotective activity. Prog Pediatr Cardiol 1998;8:49-58. (Pubitemid 28181884)
19. Au WW, Hsu TC. The genotoxic effects of adriamycin in somatic and germinal cells of the mouse. Mutat Res 1980;79:351-61. (Pubitemid 11226596)
20. Sawada T, Tamada H, Mori J. Secretion of testosterone and epidermal growth factor in mice with oligozoospermia caused by doxorubicin hydrochloride. Andrologia 1994;26:151-3. (Pubitemid 24192032)
21. Imahie H, Adachi T, Nakagawa Y, Nagasaki T, Yamamura T, Hori M. Effects of adriamycin, an anticancer drug showing testicular toxicity, on fertility in male rats. J Toxicol Sci 1995;20: 183-93.
22. Goodman J, Hochstein P. Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin. Biochem Biophys Res Commun 1977;77:797-803. (Pubitemid 8154954)
23. Pritsos CA, Sokoloff M, Gustafson DL. PZ-51 (Ebselen) in vivo protection against adriamycin-induced mouse cardiac and hepatic lipid peroxidation and toxicity. Biochem Pharmacol 1992;44:839-41.
24. Shinozawa S, Gomita Y, Araki Y. Protective effects of various drugs on adriamycin (doxorubicin)-induced toxicity and microsomal lipid peroxidation in mice and rats. Biol Pharm Bull 1993;16:1114-7. (Pubitemid 24014436)
25. Mansour MA, El-Kashef HA, Al-Shabanah OA. Effect of captopril on doxorubicin-induced nephrotoxicity in normal rats. Pharmacol Res 1999;39:233-7. (Pubitemid 29119030)
26. Manabe F, Takeshima H, Akaza H. Protecting spermatogenesis from damage induced by doxorubicin using the luteinizing hormone-releasing hormone agonist leuprorelin: An image analysis study of a rat experimental model. Cancer 1997;79: 1014-21. (Pubitemid 27089886)
27. Patil LJ, Balaraman R. Green tea extract protects doxorubicin induced testicular damage in rats. Pharmacologyonline 2008;3: 913-25.
28. El-Shenawy NS, Abdel-Nabi IM. Hypoglycemic effect of Cleome droserifolia ethanolic leaf extract in experimental diabetes, and on non-enzymatic antioxidant, glycogen, thyroid hormone and insulin levels. Diabetologia Croatica 2006;35:15-22. (Pubitemid 44935487)
29. El-Shitany NA, El-Haggar S, El-desoky K. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats. Food Chem Toxicol 2008;46:2422-8.
30. Saad SY, Najjar TA, Al-Rikabi AC. The prevention role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res 2001;43:211-8. (Pubitemid 32601427)
31. Khan N, Sultana S. Chemomodulatory effect of Ficusracemosa extract against chemically induced renal carcinogenesis and oxidative damage response in Wistar rats. Life Sci 2005;29: 1194-210. (Pubitemid 40898320)